Advertisement

Topics

BioMoti and CRO partner Pharmidex receive grant to advance cancer candidate

12:30 EDT 16 Oct 2017 | Outsourcing-Pharma

BioMoti and Pharmidex have received funding to advance proof-of-concept precision medicine studies â which if successful, could help secure pharma partnerships or additional investment, says BioMoti CEO.

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: BioMoti and CRO partner Pharmidex receive grant to advance cancer candidate

NEXT ARTICLE

More From BioPortfolio on "BioMoti and CRO partner Pharmidex receive grant to advance cancer candidate"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

Relevant Topic

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.